BoneMarrowMononuclearCells(BMMC)arelocatedinthebonemarrowandhaveregenerativecapABIlities.PrimaryBMMCareaheterogeneouspopulationofsinglenucleuscellswhichincludehematopoieticstemcells,hematopoieticProgenitorcells,immaturemonocytes,andimmaturelymphocytes[1].RecentstudiessuggestthatBMMCaresuitableasacelltherapytotreatavarietyofdiseasessuchascardiovasculardisease,type1diabetes,andischemicstroke[2,3,4].BMMCmayalsobeusedforbonetissueengineering[1].PrimarymouseBMMC(MBMMC)canbeutilizedtofurtherstudyBMMCasapotentialcelltherapy.
MBMMCfromScienCellResearchLaboratoriesareisolatedfromhealthyadultCD-1mousebonemarrow.MBMMCaredepletedoferythrocytesandbonemarrowmacrophages,cryopreservedimmediatelyafterisolation,anddeliveredfrozen.MBMMCareamixedpopulationofcellsthatincludehematopoieticstemcellsandprogenitorcells,monocytes,andlymphocytes.Eachvialcontainsatleast10millioncellsin1mlvolume.MBMMCarequalitycontroltestedforviability.MBMMCarenegativeformycoplasma,bacteria,yeast,andfungi.MBMMCcanbemaintainedforashortperiodoftimeincultureusingtheconditionsprovidedbyScienCellResearchLaboratoriesandarenotintendedforlong-termculture.
Specifications:
| CatalogNo. | M1930 |
| CountryofManufacture | UnitedStates |
| ProductCode | MBMMC |
| Size/Quantity | 10millioncellsin1mlvolume |
| ProductUse | MBMMCareforresearchuseonly.Theyarenotapprovedforhumanoranimaluse,orforapplicationininvitrodiagnosticprocedures. |
| Storage | Uponreceiving,directlyandimmediatelytransferthecellsfromdryicetoliquidnitrogenandkeepthecellsinliquidnitrogenuntiltheyareneededforexperiments. |
| ShippingInfo | Dryice. |
| References | [1]HenrichD,VerboketR,SchaIBLeA,KontradowitzK,OppermannE,BruneJ,NauC,MeierS,BonigH,MarziI,SeebachC.(2015)"CharacterizationofbonemarrowmononuclearcellsonBiomaterialsforbonetissueengineeringinvitro."BiomedResInt.10:1-12.[2]SavitzS,MisraV,KasamM,JunejaH.,CoxC,AldermanS,etal.(2011)."Intravenousautologousbonemarrowmononuclearcellsforischemicstroke."AnnNeurol.70:59-69.[3]FotinoC,RicordiC,LauriolaV,AlejandroR,PileggiA.(2010)"Bonemarrow-derivedstemcelltransplantationforthetreatmentofinsulin-dependentdiabetes."RevDiabetStud.7(2):144-157.[4]ArnousS,MozidA,MartinJ,MathurA.(2012)"Bonemarrowmononuclearcellsandacutemyocardialinfarction."StemCellRes.3(1):2-10. |
美国Sciencell 研究实验室（ScienCell）是一家生物技术公司，其宗旨是研究和细胞和细胞发育相关的实验和治疗的产品。该ScienCell技术提供了高质量的正常人体和动物的各种细胞，细胞培养基和试剂，中补充，细胞源性核糖核酸，基因和蛋白质的研究团体。在ScienCell科学家还在研究和开发细胞治疗策略，将大大改善通过实现细胞的能力，打击贩运退行性疾病的生活质量。我们的总部设在加利福尼亚州圣迭戈，并于1999年设立。
本网站将在规定时间内给予删除等相关处理。
